← Back to Search

Reat ETM and Hypothetical ETM for Smoking/Cigarette Smoking

N/A
Waitlist Available
Led By Warren K Bickel, Ph.D.
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial compares in-lab and remote medical procedures to see which works best for buying medical supplies.

Who is the study for?
This trial is for individuals who are at least 21 years old, have been smoking consistently for the past three months, and smoke a minimum of five cigarettes daily. They must not use other tobacco products often, be able to give informed consent, and have internet access. People with uncontrolled health issues or those planning to quit smoking soon cannot participate.Check my eligibility
What is being tested?
The study is examining two methods related to cigarette smoking: in-lab and remote procedures using both hypothetical and real ETM (presumably a measure related to tobacco use) purchase outcomes. It aims to see if these different settings yield comparable results.See study design
What are the potential side effects?
Since this trial involves behavioral assessments rather than medical treatments, traditional side effects like you might expect from drugs are not applicable here.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cigarette demand
Nicotine/tobacco products substitution

Trial Design

2Treatment groups
Experimental Treatment
Group I: Remote proceduresExperimental Treatment2 Interventions
Exclusive cigarette smokers will be recruited and will experience all study procedures remotely.
Group II: In-lab proceduresExperimental Treatment2 Interventions
Exclusive cigarette smokers will be recruited and will experience all study procedures in the laboratory.

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
141 Previous Clinical Trials
27,657 Total Patients Enrolled
Warren K Bickel, Ph.D.Principal InvestigatorFralin Biomedical Research Institute at VTC
5 Previous Clinical Trials
915 Total Patients Enrolled

Media Library

In-lab procedures Clinical Trial Eligibility Overview. Trial Name: NCT05946031 — N/A
Smoking/Cigarette Smoking Research Study Groups: In-lab procedures, Remote procedures
Smoking/Cigarette Smoking Clinical Trial 2023: In-lab procedures Highlights & Side Effects. Trial Name: NCT05946031 — N/A
In-lab procedures 2023 Treatment Timeline for Medical Study. Trial Name: NCT05946031 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant spots in this experiment open to participants?

"The trial's page on clinicaltrials.gov discloses that this specialised study is not actively looking for participants, despite being initially posted in August 15th 2023 and lastly edited July 6th 2023. Fortunately, there are 49 other studies recruiting patients at the present time."

Answered by AI
~73 spots leftby Aug 2025